**Core Concept**
Pulmonary adenocarcinoma is a type of non-small cell lung cancer (NSCLC) characterized by its histological and molecular features. The classification of pulmonary adenocarcinoma is crucial for determining prognosis and guiding treatment decisions.

**Why the Correct Answer is Right**
The International Association for the Study of Lung Cancer (IASLC) proposed a new classification system for pulmonary adenocarcinoma in 2011, which is widely accepted. This system divides adenocarcinoma into five subtypes based on their histological patterns:
* Lepidic (formerly bronchioloalveolar carcinoma)
* Acinar
* Papillary
* Micropapillary
* Solid
This classification helps in identifying the molecular characteristics and genetic alterations associated with each subtype, which in turn guides targeted therapy.

**Why Each Wrong Option is Incorrect**
**Option A:** is incorrect because it does not refer to the IASLC classification.
**Option B:** is incorrect because it is not a specific classification system for pulmonary adenocarcinoma.
**Option D:** is incorrect because it is a different classification system, mainly used for squamous cell carcinoma.

**Clinical Pearl / High-Yield Fact**
It is essential to recognize the IASLC classification system for pulmonary adenocarcinoma, as it has significant implications for patient management and treatment decisions.

**Correct Answer: C. IASLC (International Association for the Study of Lung Cancer) classification**